Name | Number of supported studies | Average coverage | |
---|---|---|---|
precursor B cell | 4 studies | 27% ± 6% | |
plasma cell | 3 studies | 27% ± 3% | |
epithelial cell | 3 studies | 24% ± 4% | |
ciliated cell | 3 studies | 21% ± 5% |
Insufficient scRNA-seq data for expression of H2BC4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 96% | 273.02 | 234 / 245 | 97% | 81.20 | 489 / 502 |
lung | 98% | 178.37 | 564 / 578 | 73% | 22.19 | 848 / 1155 |
liver | 96% | 171.94 | 217 / 226 | 71% | 18.40 | 289 / 406 |
breast | 79% | 74.59 | 361 / 459 | 81% | 37.41 | 910 / 1118 |
kidney | 90% | 108.30 | 80 / 89 | 56% | 12.23 | 506 / 901 |
skin | 90% | 101.46 | 1627 / 1809 | 54% | 11.06 | 257 / 472 |
esophagus | 62% | 123.11 | 890 / 1445 | 79% | 20.72 | 145 / 183 |
ovary | 58% | 52.58 | 105 / 180 | 82% | 21.91 | 351 / 430 |
thymus | 77% | 57.21 | 502 / 653 | 55% | 9.33 | 332 / 605 |
bladder | 62% | 35.90 | 13 / 21 | 54% | 21.89 | 274 / 504 |
pancreas | 34% | 19.80 | 113 / 328 | 70% | 16.38 | 125 / 178 |
stomach | 63% | 71.47 | 225 / 359 | 42% | 10.47 | 120 / 286 |
uterus | 32% | 31.29 | 54 / 170 | 73% | 17.52 | 334 / 459 |
intestine | 66% | 50.79 | 634 / 966 | 39% | 10.65 | 204 / 527 |
adrenal gland | 73% | 47.69 | 188 / 258 | 29% | 5.25 | 67 / 230 |
ureter | 0% | 0 | 0 / 0 | 100% | 8.73 | 1 / 1 |
peripheral blood | 100% | 764.65 | 928 / 929 | 0% | 0 | 0 / 0 |
muscle | 97% | 200.75 | 780 / 803 | 0% | 0 | 0 / 0 |
spleen | 97% | 114.40 | 234 / 241 | 0% | 0 | 0 / 0 |
adipose | 88% | 72.25 | 1062 / 1204 | 0% | 0 | 0 / 0 |
brain | 64% | 44.46 | 1696 / 2642 | 19% | 2.69 | 135 / 705 |
blood vessel | 77% | 49.35 | 1034 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 76% | 11.63 | 34 / 45 |
heart | 72% | 49.63 | 618 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 45% | 6.28 | 13 / 29 |
eye | 0% | 0 | 0 / 0 | 20% | 2.41 | 16 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
No associated gene sets found.
Gene name | H2BC4 |
Protein name | Histone H2B type 1-C/E/F/G/I (Histone H2B.1 A) (Histone H2B.a) (H2B/a) (Histone H2B.g) (H2B/g) (Histone H2B.h) (H2B/h) (Histone H2B.k) (H2B/k) (Histone H2B.l) (H2B/l) HIST1H2BC protein |
Synonyms | H2BC10 H2BFA HIST1H2BE; H2BC7 H2BFK H2BFG H2BFL H2BFH HIST1H2BF; HIST1H2BG; HIST1H2BI H2BC6 H2BC8 HIST1H2BC HIST1H2BC; |
Description | FUNCTION: Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling.; FUNCTION: Has broad antibacterial activity. May contribute to the formation of the functional antimicrobial barrier of the colonic epithelium, and to the bactericidal activity of amniotic fluid. FUNCTION: Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling. . |
Accessions | ENST00000314332.5 P62807 ENST00000541790.4 Q0D2M2 ENST00000614097.3 ENST00000356530.6 ENST00000634910.1 ENST00000707188.1 ENST00000396984.2 ENST00000377733.4 |